A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc.
Eli Lilly and Company
Revolution Medicines, Inc.
PAQ Therapeutics, Inc.
Fate Therapeutics
Fate Therapeutics
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center